Trials / Completed
CompletedNCT05593926
Fibre suppLements fOR Pre-diAbetes - An Assessment Oral Fibre Supplements on Pre-diabetes Outcome Measures
Fibre suppLements fOR Pre-diAbetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- Myota GmbH · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This trial will investigate whether a powdered fibre mix helps maintain healthy blood glucose levels in participants with pre-diabetes, where high blood sugar is a risk of diabetes.
Detailed description
Pre-diabetes is characterised by high blood glucose levels, high plasma cholesterol, low-density lipoprotein (LDL) and high-density lipoprotein (HDL). Dietary fibre consumption has been hypothesised to improve these metabolic parameters through the viscous properties, and the production of short-chain fatty acids (SCFA) in the intestine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Myota Metabolic Regulator | The functional food, Myota Metabolic Regulator, consisting of 20g of a powdered fibre mix, to be taken daily alongside usual diet for 24 weeks. |
Timeline
- Start date
- 2022-11-16
- Primary completion
- 2023-08-26
- Completion
- 2024-01-15
- First posted
- 2022-10-26
- Last updated
- 2024-01-17
Locations
2 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05593926. Inclusion in this directory is not an endorsement.